PFKFB4 and breast carcinoma: Our study revealed that almost half (49.0%, 98/200) of the breast cancer cases in our study had a score 3 (the highest) for PFKFB4 staining, which indicate a large population of breast cancer patients deposit the potential therapeutic target.